IDiyas

For the Inventor, By the Inventor

Beijing, China

Huai Huang

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 11.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal5 out of 17 
 
Beijing Tide Pharmaceutical Co., Ltd.
 patents

Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):
1. 12459917 - Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use thereof (2025-11-04),
2. 12365665 - Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof (2025-07-22),
3. 12180243 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2024-12-31),
4. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof (2024-02-20),
5. 11453690 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2022-09-27),

Title: **Innovative Contributions of Huai Huang: A Focus on Pharmaceutical Advancements**

Introduction

Huai Huang, an accomplished inventor based in Beijing, China, has made significant contributions to the field of pharmaceuticals. With a prolific record of three patents, his work is at the forefront of innovative pharmaceutical solutions aimed at addressing critical health challenges.

Latest Patents

Among his latest patents is an innovative receptor inhibitor, along with a pharmaceutical composition comprising the same, which details its applications and uses. This invention discloses a receptor inhibitor of formula (I) that has potential therapeutic applications, showcasing Huai's commitment to advancing medical science. His other patent, similar in theme, also focuses on receptor inhibitors and their compositions, underscoring the importance of this research in modern medicine.

Career Highlights

Huai Huang is associated with Beijing Tide Pharmaceutical Co., Ltd., a company known for its dedication to developing groundbreaking pharmaceutical products. His work not only reflects individual ingenuity but also aligns with the company's mission of promoting health through innovation.

Collaborations

In his career, Huai has had the opportunity to collaborate with esteemed colleagues such as Yanping Zhao and Hongjun Wang. These professional relationships have likely fostered a collaborative environment that enhances creativity and drives further innovation in their research endeavors.

Conclusion

Huai Huang's innovative patents and collaborative spirit exemplify the essence of progress in the pharmaceutical industry. His dedication to developing receptor inhibitors highlights the crucial role that inventors play in advancing healthcare solutions and improving patient outcomes. As the field of pharmaceuticals continues to evolve, Huai's contributions will undoubtedly leave a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…